NeuroMetrix (NURO)

• Market cap: $8.8M
• 1 day: 4.11%
• 5 days: -0.69%
• 1 month: 21.41%
• 3 months: 12.83%
• 6 months: 12.53%
• Year to date: 25.29%
• 1 year: 16.49%
• 5 years: -88.91%
• 10 years: -99.90%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Employees: 26

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

27% more funds holding

Funds holding: 11 [Q2] → 14 (+3) [Q3]

20% more capital invested

Capital invested by funds: $205K [Q2] → $246K (+$40.9K) [Q3]

0.25% more ownership

Funds ownership: 2.76% [Q2] → 3.01% (+0.25%) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3